Alto Ingredients, Inc. (USD) Alto Ingredients, Inc., operating within the United States, specializes in the production and commercialization of both specialty alcohols and various essential ingredients. Its operations are structured into three distinct segments: Marketing and Distribution, Pekin Production, and Other Production. The company's diverse product portfolio includes a range of specialty alcohols, which find applications across the health, home, and beauty sectors. These alcohols are key components in products such as mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and various cleaning solutions. Additionally, Alto Ingredients supplies grain neutral spirits, vital for alcoholic beverages, flavor extracts, and vinegar production. It also provides corn germ for corn oil manufacturing and carbon dioxide, primarily serving the food and beverage industries. Its essential ingredients segment encompasses a variety of products critical for commercial animal feed and pet food formulations, including dried yeast, corn gluten meal, corn gluten feed, distillers grains, and liquid feed. Furthermore, the company is a supplier of fuel-grade ethanol, primarily utilized as a transportation fuel, and distillers corn oil, which serves as a feedstock for biodiesel production. Notably, some of the fuel-grade ethanol it offers is sourced from third-party producers. Beyond manufacturing, Alto Ingredients facilitates transportation, storage, and delivery services for its products, leveraging a network of third-party service providers. Its diverse customer base includes integrated oil companies and gasoline marketers for its ethanol products; dairies and feedlots for essential ingredient feedstuffs; and poultry and biodiesel manufacturers for its corn oil. The company boasts five alcohol production facilities: three strategically located in the Midwestern state of Illinois, and two further west in Oregon and Idaho. Headquartered in Pekin, Illinois, Alto Ingredients, Inc. was established in 2003. The company underwent a significant rebranding in January 2021, changing its name from its former identity, Pacific Ethanol, Inc.

Alto Ingredients, Inc. (USD) Active

1300 South Second Street, Pekin, IL, US, 61554

Stock Price USD

Price Change

Last Dividend USD

B+

Latest Rating

ALTO's stock peer is FEAM (5E Advanced Materials Inc.)

ALTO's stock peer is GORO (Gold Resource Corporation)

ALTO's stock peer is GRO (Brazil Potash Corp.)

ALTO's stock peer is LOOP (Loop Industries, Inc.)

ALTO's stock peer is NEXM (Nexmetals Mining Corp.)

ALTO's stock peer is NTIC (Northern Technologies International Corporation)

ALTO's stock peer is ORGN (Origin Materials, Inc.)

ALTO's stock peer is PZG (Paramount Gold Nevada Corp.)

Basic Materials Chemicals - Specialty

Alto Ingredients, Inc., operating within the United States, specializes in the production and commercialization of both specialty alcohols and various essential ingredients. Its operations are structured into three distinct segments: Marketing and Distribution, Pekin Production, and Other Production. The company's diverse product portfolio includes a range of specialty alcohols, which find applications across the health, home, and beauty sectors. These alcohols are key components in products such as mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and various cleaning solutions. Additionally, Alto Ingredients supplies grain neutral spirits, vital for alcoholic beverages, flavor extracts, and vinegar production. It also provides corn germ for corn oil manufacturing and carbon dioxide, primarily serving the food and beverage industries. Its essential ingredients segment encompasses a variety of products critical for commercial animal feed and pet food formulations, including dried yeast, corn gluten meal, corn gluten feed, distillers grains, and liquid feed. Furthermore, the company is a supplier of fuel-grade ethanol, primarily utilized as a transportation fuel, and distillers corn oil, which serves as a feedstock for biodiesel production. Notably, some of the fuel-grade ethanol it offers is sourced from third-party producers. Beyond manufacturing, Alto Ingredients facilitates transportation, storage, and delivery services for its products, leveraging a network of third-party service providers. Its diverse customer base includes integrated oil companies and gasoline marketers for its ethanol products; dairies and feedlots for essential ingredient feedstuffs; and poultry and biodiesel manufacturers for its corn oil. The company boasts five alcohol production facilities: three strategically located in the Midwestern state of Illinois, and two further west in Oregon and Idaho. Headquartered in Pekin, Illinois, Alto Ingredients, Inc. was established in 2003. The company underwent a significant rebranding in January 2021, changing its name from its former identity, Pacific Ethanol, Inc.

20%

Dcf Rating

80%

Return On Equity

100%

Return On Assets

40%

Debt To Equity

60%

Price To Earnings

60%

Price To Book

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Recent News

ALTO Announces Full-Building Lease With a Major 3rd Party Logistics Company at ALTO Pinto 45

DALLAS--(BUSINESS WIRE)--ALTO Real Estate Funds is pleased to announce the successful execution of a full-building lease with a major 3rd party logistics company at ALTO Pinto 45, a 586,919 SF Class A industrial facility in South Dallas. The lease marks a major milestone for the project, delivering 100% occupancy and securing a global logistics leader as the long-term tenant. With lease execution completed in May 2026 and operations expected to commence in August 2026, this transaction reinforc.

2026-06-24 06:22:00

ALTO Announces Full-Building Lease with DHL at ALTO Pinto 45

DALLAS--(BUSINESS WIRE)--ALTO Real Estate Funds is pleased to announce the successful execution of a full-building lease with DHL at ALTO Pinto 45, a 586,919 SF Class A industrial facility in South Dallas. The lease marks a major milestone for the project, delivering 100% occupancy and securing a global logistics leader as the long-term tenant. With lease execution completed in May 2026 and operations expected to commence in August 2026, this transaction reinforces the strength of the Dallas lo.

2026-06-22 07:21:00

Alto Ingredients, Inc. Completes Transaction to Monetize All 2025 45Z Clean Fuel Production Tax Credits

PEKIN, Ill., June 15, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that it has completed a sale transaction with a third-party corporate buyer for all of Alto Ingredients' 2025 Section 45Z Clean Fuel Production Tax Credits generated from its low-carbon ethanol production.

2026-06-15 08:30:00

Alto Ingredients, Inc. to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference

PEKIN, Ill., May 18, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, announced that management is scheduled to participate at the Craig-Hallum 23rd Annual Institutional Investor Conference on Thursday, May 28, 2026, in Minneapolis, MN.

2026-05-18 08:30:00

Alto Ingredients, Inc. Reports First Quarter 2026 Results

Q1 2026 Gross Profit of $9.2 Million Increased $11.0 Million Q1 2026 Net Income of $4.0 Million, or $0.05 per Share, Improved $16.0 Million Q1 2026 Adjusted EBITDA of $4.7 Million Improved $9.1 Million Compared to Q1 2025 PEKIN, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, reported its financial results for the quarter ended March 31, 2026.

2026-05-06 16:05:00

Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a randomized, single-blind, placebo-controlled Phase 2a trial of ALTO-207 (formerly CTC-501) in patients with Major Depressive Disorder (MDD). The data were presented in a poster session at the 2026 Annual Meeting of the Society of Biological Psychiatry (SOBP). ALTO-20.

2026-05-04 08:03:00

Alto Ingredients, Inc. to Release First Quarter 2026 Financial Results on May 6, 2026

PEKIN, Ill., April 30, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, announced it will release its first quarter 2026 financial results after the close of market on Wednesday, May 6, 2026.

2026-04-30 08:30:00

Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the initiation of a Phase 2b randomized, placebo-controlled trial of ALTO-207 in treatment-resistant depression (TRD), a program designed to replicate the strongly positive PAX-D study results and support a streamlined path to registration. TRD is estimated to affect up to 7 million adults in the U.

2026-04-21 08:03:00

Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced topline data from its Phase 2 proof-of-concept (POC) clinical trial evaluating ALTO-101 for the treatment of cognitive impairment associated with schizophrenia (CIAS), and provided an update on the Company's pipeline and prioritization. ALTO-101 did not achieve statistical significance on primary e.

2026-04-01 16:30:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions